Odonate Statistics
Total Valuation
Odonate has a market cap or net worth of 53.25 million.
| Market Cap | 53.25M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Odonate has 355 shares outstanding.
| Current Share Class | 355 |
| Shares Outstanding | 355 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.75 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.29, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.29 |
| Quick Ratio | 3.14 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -86.14% and return on invested capital (ROIC) is -40.80%.
| Return on Equity (ROE) | -86.14% |
| Return on Assets (ROA) | -33.09% |
| Return on Invested Capital (ROIC) | -40.80% |
| Return on Capital Employed (ROCE) | -106.89% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -703,903 |
| Employee Count | 145 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.05% in the last 52 weeks. The beta is -0.10, so Odonate's price volatility has been lower than the market average.
| Beta (5Y) | -0.10 |
| 52-Week Price Change | +19.05% |
| 50-Day Moving Average | 133,764.32 |
| 200-Day Moving Average | 136,795.08 |
| Relative Strength Index (RSI) | 54.04 |
| Average Volume (20 Days) | 0 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -80.68M |
| Pretax Income | -102.07M |
| Net Income | -102.07M |
| EBITDA | -80.18M |
| EBIT | -80.68M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 95.03 million in cash and 4.85 million in debt, giving a net cash position of 90.18 million or 254,025.35 per share.
| Cash & Cash Equivalents | 95.03M |
| Total Debt | 4.85M |
| Net Cash | 90.18M |
| Net Cash Per Share | 254,025.35 |
| Equity (Book Value) | 71.37M |
| Book Value Per Share | 148,380.46 |
| Working Capital | 69.29M |
Cash Flow
In the last 12 months, operating cash flow was -94.54 million and capital expenditures -42,000, giving a free cash flow of -94.58 million.
| Operating Cash Flow | -94.54M |
| Capital Expenditures | -42,000 |
| Free Cash Flow | -94.58M |
| FCF Per Share | -266,419.72 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Odonate does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -191.67% |
| FCF Yield | -177.61% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 15, 2025. It was a reverse split with a ratio of 0.125.
| Last Split Date | Jan 15, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.125 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |